Top Tweets for #IGAV
IgA vasculitis in adults can be challenging to navigate.
This episode explores clinical decision making, treatment considerations, and guideline insights.
🎧 Tune in: https://t.co/RGuDW0NrDB (Episode 056)
#Nephrology #KidneyHealth #IgAN #IgAV #KDOQI #KDIGO
🇷🇴 VIGOROUS WARRIOR 2026: Misiune încheiată pentru echipa României 🎖️
Exercițiul multinațional Vigorous Warrior 2026 (VW26) a ajuns la final. 🏁
Comunicatul integral:
https://t.co/P9kF3WQW6a
#DSU #IGSU #IGAv #SAJ #SABIF #UPU #CPU #Salvamont #situatiideurgenta #VW26
Excellent presentation @louise_oni at @anzvasc
Raising the voice of children with IgA vasculitis and hoping for a better future, more data, more treatments!
#vasculitis #IVW26 #IgAV @_ERNRITA @ukivas
IgA vasculitis isn’t always benign.
• Children → often self-limiting
• Adults → chronic, relapsing, kidney-driven disease
Palpable purpura is just the tip of the iceberg.
Know the four-hit hypothesis.
Watch the kidneys.
#IgAV #MedTwitter #Vasculitis @DrAkhilX @IhabFathiSulima #RheumTwitter #Nephrology
1️⃣ Palpable Purpura
The classic small-vessel vasculitis lesion.
✅ Non-blanching, raised spots, usually on the lower legs.
📌 Think leukocytoclastic vasculitis, cryoglobulinemia, IgA vasculitis.
KDIGO is excited to share the publication of the 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV), along with the Executive Summary in @Kidney_Int.
Read the Guideline in KI: https://t.co/OvxwTGjjXx
Download the Executive Summary: https://t.co/WLJLwFnlZq
Read the News Release: https://t.co/gHZ1yvcuoe
Co-chaired by Dr. Jürgen Floege (DE) and @BradRovin, this update to the 2021 KDIGO Glomerular Diseases Guideline on IgAN incorporates evidence through August 2024. Given the rapid pace of discovery, KDIGO will continue to update the guideline regularly so clinicians and patients have access to the latest science and recommendations.
“This guideline represents a fundamental shift in how we approach IgA nephropathy,” said Dr. Floege. “For the first time, we can target both the immune mechanisms driving IgA injury and the kidney’s maladaptive responses. This dual strategy offers a roadmap to slow progression and extend kidney survival in ways not possible just a few years ago.”
“The science is moving faster than ever, and the treatment landscape has changed dramatically,” said Dr. Rovin. “With therapies like targeted-release budesonide, sparsentan, and SGLT2 inhibitors, we can intervene earlier and tailor care. We are moving from a single approach to a toolkit of therapies that can truly change outcomes for people around the world."
Download the Guideline: https://t.co/NUzPHXN4Zu
KDIGO is excited to share the publication of the 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV), along with the Executive Summary in @Kidney_Int.
Read the Guideline in KI: https://t.co/OvxwTGjjXx
Download the Executive Summary: https://t.co/WLJLwFnlZq
Read the News Release: https://t.co/gHZ1yvcuoe
Co-chaired by Dr. Jürgen Floege (DE) and @BradRovin, this update to the 2021 KDIGO Glomerular Diseases Guideline on IgAN incorporates evidence through August 2024. Given the rapid pace of discovery, KDIGO will continue to update the guideline regularly so clinicians and patients have access to the latest science and recommendations.
“This guideline represents a fundamental shift in how we approach IgA nephropathy,” said Dr. Floege. “For the first time, we can target both the immune mechanisms driving IgA injury and the kidney’s maladaptive responses. This dual strategy offers a roadmap to slow progression and extend kidney survival in ways not possible just a few years ago.”
“The science is moving faster than ever, and the treatment landscape has changed dramatically,” said Dr. Rovin. “With therapies like targeted-release budesonide, sparsentan, and SGLT2 inhibitors, we can intervene earlier and tailor care. We are moving from a single approach to a toolkit of therapies that can truly change outcomes for people around the world."
Download the Guideline: https://t.co/NUzPHXN4Zu
🎯📷 KDIGO acaba de publicar publica la Guía de Práctica Clínica 2025 para el manejo de la nefropatía IgA (#IgAN) y la vasculitis IgA (#IgAV), junto con el Resumen Kidney International. No te lo pierdas👇👇
👉 Guía completa: https://t.co/5Wml6m6nwY
@SENefrologia
@SOMANEorg
KDIGO is excited to share the publication of the 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV), along with the Executive Summary in @Kidney_Int.
Read the Guideline in KI: https://t.co/OvxwTGjjXx
Download the Executive Summary: https://t.co/WLJLwFnlZq
Read the News Release: https://t.co/gHZ1yvcuoe
Co-chaired by Dr. Jürgen Floege (DE) and @BradRovin, this update to the 2021 KDIGO Glomerular Diseases Guideline on IgAN incorporates evidence through August 2024. Given the rapid pace of discovery, KDIGO will continue to update the guideline regularly so clinicians and patients have access to the latest science and recommendations.
“This guideline represents a fundamental shift in how we approach IgA nephropathy,” said Dr. Floege. “For the first time, we can target both the immune mechanisms driving IgA injury and the kidney’s maladaptive responses. This dual strategy offers a roadmap to slow progression and extend kidney survival in ways not possible just a few years ago.”
“The science is moving faster than ever, and the treatment landscape has changed dramatically,” said Dr. Rovin. “With therapies like targeted-release budesonide, sparsentan, and SGLT2 inhibitors, we can intervene earlier and tailor care. We are moving from a single approach to a toolkit of therapies that can truly change outcomes for people around the world."
Download the Guideline: https://t.co/NUzPHXN4Zu
🚨New: #KDIGO 2025 #Guideline for #IgAN & #IgAV!
Targets🎯
✅Block IgA/IC formation & injury
✅Lower proteinuria/hyperfiltration
✅Control BP & CV risk
🩺Tx: Nefecon, SGLT2i, RAASi, steroids + more
👉🏻Consider clinical trials
🔗 https://t.co/KNTW71yCc4 🆕 🆓
#Nephrology #CKD
KDIGO is excited to share the publication of the 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV), along with the Executive Summary in @Kidney_Int.
Read the Guideline in KI: https://t.co/OvxwTGjjXx
Download the Executive Summary: https://t.co/WLJLwFnlZq
Read the News Release: https://t.co/gHZ1yvcuoe
Co-chaired by Dr. Jürgen Floege (DE) and @BradRovin, this update to the 2021 KDIGO Glomerular Diseases Guideline on IgAN incorporates evidence through August 2024. Given the rapid pace of discovery, KDIGO will continue to update the guideline regularly so clinicians and patients have access to the latest science and recommendations.
“This guideline represents a fundamental shift in how we approach IgA nephropathy,” said Dr. Floege. “For the first time, we can target both the immune mechanisms driving IgA injury and the kidney’s maladaptive responses. This dual strategy offers a roadmap to slow progression and extend kidney survival in ways not possible just a few years ago.”
“The science is moving faster than ever, and the treatment landscape has changed dramatically,” said Dr. Rovin. “With therapies like targeted-release budesonide, sparsentan, and SGLT2 inhibitors, we can intervene earlier and tailor care. We are moving from a single approach to a toolkit of therapies that can truly change outcomes for people around the world."
Download the Guideline: https://t.co/NUzPHXN4Zu
La Multi Ani Pompierilor Romani! Sa va intoarceti intotdeauna sanatosi acasa! #Mai #DSU #IGSU #igav #pompierii #situatiideurgenta #salvatorii #sistemintegrat #mereuladatorie
Am lansat pe pagina https://t.co/qwfZkzHdzD primul film educational destinat adolescentilor. Filmul este realizat cu sprijinul @UNICEFRomania carora le multumesc pentru sprijinul acordat. #MAI #DSU #IGSU #IGAV #UNICEF #UNCEFROMANIA
👶 Pediatric IgA nephropathy & IgA vasculitis nephritis—2 faces of the same IgA storm!
💡Must-see updated IPNA 2025 guidelines 🫘
🎯 Practical, visual, evidence-based 📚
🔗https://t.co/ZJxdXYV4Zc
#MedTwitter #PedsNeph #FOAMed #IgAN #IgAV #Guidelines #Pediatrics #Nephrology
Telitacicept as a BAFF/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis
#IgAV
https://t.co/ltIBTSIxZY
O nouă misiune de transfer aerian a 4 pacienți cu arsuri, din Republica Macedonia de Nord
Mai multe informații ⤵️
https://t.co/o4ZIeQrLjf
#DSU #IGSU #IGAv #SAJ #SABIf #UPU #CPU #Salvamont #situatiideurgenta #sistemintegrat #mereuladatorie #pompierii #salvatorii
Ce poți face pentru a limita efectele dezastruoase ale unui incendiu? Poți monta detectoare de fum și de monoxid de carbon, pentru a te alerta înainte ca totul să ia amploare.
#DSU #IGSU #IGAv #SAJ #SABIf #UPU #CPU #Salvamont #situatiideurgenta #sistemintegrat #Stiaica
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.7M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.7M followers
Taylor Swift
@taylorswift13
81.6M followers
Lady Gaga
@ladygaga
73.1M followers
Virat Kohli
@imvkohli
70M followers
Kim Kardashian
@kimkardashian
69.8M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.9M followers
Neymar Jr
@neymarjr
62.7M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.8M followers